97 related articles for article (PubMed ID: 6406978)
1. Influence of age on serogroup distribution of endemic meningococcal disease.
Baker CJ; Griffiss JM
Pediatrics; 1983 Jun; 71(6):923-6. PubMed ID: 6406978
[TBL] [Abstract][Full Text] [Related]
2. Increased case-fatality rate associated with outbreaks of Neisseria meningitidis infection, compared with sporadic meningococcal disease, in the United States, 1994-2002.
Brooks R; Woods CW; Benjamin DK; Rosenstein NE
Clin Infect Dis; 2006 Jul; 43(1):49-54. PubMed ID: 16758417
[TBL] [Abstract][Full Text] [Related]
3. The changing epidemiology of meningococcal disease in the United States, 1992-1996.
Rosenstein NE; Perkins BA; Stephens DS; Lefkowitz L; Cartter ML; Danila R; Cieslak P; Shutt KA; Popovic T; Schuchat A; Harrison LH; Reingold AL
J Infect Dis; 1999 Dec; 180(6):1894-901. PubMed ID: 10558946
[TBL] [Abstract][Full Text] [Related]
4. Multicenter surveillance of invasive meningococcal infections in children.
Kaplan SL; Schutze GE; Leake JA; Barson WJ; Halasa NB; Byington CL; Woods CR; Tan TQ; Hoffman JA; Wald ER; Edwards KM; Mason EO
Pediatrics; 2006 Oct; 118(4):e979-84. PubMed ID: 17015517
[TBL] [Abstract][Full Text] [Related]
5. Age dependence of in vitro survival of meningococci in whole blood during childhood.
Ison CA; Anwar N; Cole MJ; Pollard AJ; Morley SL; Fidler K; Sandiford C; Banks J; Kroll SJ; Levin M
Pediatr Infect Dis J; 2003 Oct; 22(10):868-73. PubMed ID: 14551486
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Neisseria meningitidis strains isolated from invasive meningococcal disease cases in Canada in 2001.
Tsang RS; Squires SG; Tam TW
Can J Microbiol; 2003 Oct; 49(10):633-8. PubMed ID: 14663497
[TBL] [Abstract][Full Text] [Related]
7. Meningococcal disease--management of serogroup C clusters in a hyperendemic area.
Dell E; Bedford D; McMahon B; Nicholson A
Ir Med J; 2001 Jun; 94(6):166, 168-9. PubMed ID: 11495231
[TBL] [Abstract][Full Text] [Related]
8. Polymerase chain reaction for diagnosis and serogrouping of meningococcal disease in children.
Munoz-Almagro C; Rodriguez-Plata MT; Marin S; Esteva C; Esteban E; Gene A; Gelabert G; Jordan I
Diagn Microbiol Infect Dis; 2009 Feb; 63(2):148-54. PubMed ID: 19026504
[TBL] [Abstract][Full Text] [Related]
9. Recent epidemiological changes in meningococcal disease may be due to the displacement of serogroup A by serogroup C in Hefei City, China.
Ni JD; Jin YH; Dai B; Wang XP; Liu DQ; Chen X; Zheng Y; Ye DQ
Postgrad Med J; 2008 Feb; 84(988):87-92. PubMed ID: 18322129
[TBL] [Abstract][Full Text] [Related]
10. Global epidemiology of meningococcal disease.
Harrison LH; Trotter CL; Ramsay ME
Vaccine; 2009 Jun; 27 Suppl 2():B51-63. PubMed ID: 19477562
[TBL] [Abstract][Full Text] [Related]
11. Annual report of the Australian Meningococcal Surveillance Programme, 1999.
Commun Dis Intell; 2000 Jul; 24(7):181-9. PubMed ID: 10981347
[TBL] [Abstract][Full Text] [Related]
12. [Meningococcal disease in Spain, 1990-1997. Change in its epidemiological pattern].
de Mateo Ontañón S
Rev Esp Salud Publica; 2000; 74(4):387-96. PubMed ID: 11031848
[TBL] [Abstract][Full Text] [Related]
13. Serogroup C meningococcal outbreaks in the United States. An emerging threat.
Jackson LA; Schuchat A; Reeves MW; Wenger JD
JAMA; 1995 Feb; 273(5):383-9. PubMed ID: 7823383
[TBL] [Abstract][Full Text] [Related]
14. Serogroup Y meningococcal disease--Illinois, Connecticut, and selected areas, United States, 1989-1996.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1996 Nov; 45(46):1010-3. PubMed ID: 8965799
[TBL] [Abstract][Full Text] [Related]
15. Neisseria meningitidis carriage during an outbreak of serogroup C disease.
Patrick DM; Champagne S; Goh SH; Arsenault G; Thomas E; Shaw C; Rahim T; Taha F; Bigham M; Dubenko V; Skowronski D; Brunham RC
Clin Infect Dis; 2003 Nov; 37(9):1183-8. PubMed ID: 14557962
[TBL] [Abstract][Full Text] [Related]
16. Meningococcal B vaccine: new drug. The only vaccine against some serogroup B meningococci.
Prescrire Int; 2008 Jun; 17(95):95-7. PubMed ID: 18623907
[TBL] [Abstract][Full Text] [Related]
17. Development of the epidemiological situation in invasive meningococcal disease in the Czech Republic caused by emerging Neisseria meningitidis clone ET-15/37.
Krízová P; Musílek M; Kalmusová J
Cent Eur J Public Health; 1997 Dec; 5(4):214-8. PubMed ID: 9457424
[TBL] [Abstract][Full Text] [Related]
18. Annual report of the Australian Meningococcal Surveillance Programme, 1998. The Australian Meningococcal Surveillance Programme.
Commun Dis Intell; 1999 Nov; 23(12):317-23. PubMed ID: 10615794
[TBL] [Abstract][Full Text] [Related]
19. Bacteriocins (meningocins) in Norwegian isolates of Neisseria meningitidis: possible role in the course of a meningococcal epidemic.
Allunans J; Kristiansen KI; Assalkhou R; Bjørås M
APMIS; 2008 May; 116(5):333-44. PubMed ID: 18452423
[TBL] [Abstract][Full Text] [Related]
20. Meningococcal C vaccines: the Canadian experience.
De Wals P
Pediatr Infect Dis J; 2004 Dec; 23(12 Suppl):S280-4. PubMed ID: 15597070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
